» Authors » Barry G Rosser

Barry G Rosser

Explore the profile of Barry G Rosser including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 203
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karime C, Vattikonda A, Hashash J, Rosser B, Merchea A, Stocchi L, et al.
Crohns Colitis 360 . 2024 Jul; 6(3):otae037. PMID: 38966121
Background: Colorectal surgery in patients with inflammatory bowel disease (IBD) and cirrhosis has increased morbidity, which may preclude surgery. Preoperative transjugular intrahepatic portosystemic shunt (TIPS) is postulated to reduce surgical...
2.
Wadei H, Heckman M, Rawal B, Taner C, Mai M, Cortese C, et al.
Transplantation . 2014 Jun; 98(12):1323-30. PMID: 24914572
Background: Kidney biopsy has been recommended to guide kidney allocation in selected liver transplant (LT) candidates with renal dysfunction. However, post-LT-alone renal outcomes in recipients who showed evidence of reversible...
3.
Wadei H, Bulatao I, Gonwa T, Mai M, Prendergast M, Keaveny A, et al.
Liver Transpl . 2014 Mar; 20(6):728-35. PMID: 24648186
Limited data are available for outcomes of simultaneous liver-kidney (SLK) transplantation using donation after cardiac death (DCD) donors. The outcomes of 12 DCD-SLK transplants and 54 SLK transplants using donation...
4.
Yataco M, Difato T, Bargehr J, Rosser B, Patel T, Trejo-Gutierrez J, et al.
Liver Int . 2014 Feb; 34(6):e105-10. PMID: 24529030
Background & Aims: Non-ischaemic cardiomyopathy (NIC) is an early complication of liver transplantation (LT). Our aims were to define the prevalence, associated clinical factors, and prognosis of this condition. Methods:...
5.
Pungpapong S, Aqel B, Koning L, Murphy J, Henry T, Ryland K, et al.
Liver Transpl . 2013 May; 19(7):690-700. PMID: 23696372
The safety, efficacy, and effect on immunosuppression levels of telaprevir (TVR) or boceprevir (BOC) in combination with peginterferon (PEG-IFN) and ribavirin (RBV) in recipients of liver transplantation (LT) with hepatitis...
6.
Sibulesky L, Heckman M, Taner C, Canabal J, Diehl N, Perry D, et al.
World J Hepatol . 2013 Feb; 5(1):26-32. PMID: 23383363
Aim: To determine feasibility of liver transplantation in patients from the intensive care unit (ICU) by estimating graft and patient survival. Methods: This single center retrospective study included 39 patients...
7.
Taner C, Bulatao I, Arasi L, Perry D, Willingham D, Sibulesky L, et al.
Ann Hepatol . 2012 Sep; 11(5):679-85. PMID: 22947529
 Patients with end stage liver disease may become critically ill prior to LT requiring admission to the intensive care unit (ICU). The high acuity patients may be thought too ill...
8.
Taner C, Ung R, Rosser B, Aranda-Michel J
Hepatol Int . 2011 Jun; 6(1):403-7. PMID: 21688082
Introduction: Transplant community has arbitrary age limit for liver transplantation based on the increased comorbidities in aging population. There has been an increased demand to consider older patients to have...
9.
Taner C, Bulatao I, Keaveny A, Willingham D, Pungpapong S, Perry D, et al.
Liver Transpl . 2011 May; 17(6):641-9. PMID: 21618684
Hepatitis C virus (HCV) infection is the most common indication for orthotopic liver transplantation in the United States. Although studies have addressed the use of expanded criteria donor organs in...
10.
Taner C, Balci D, Willingham D, Keaveny A, Rosser B, Canabal J, et al.
Exp Clin Transplant . 2011 Apr; 9(2):98-104. PMID: 21510102
Objectives: Orthotopic liver transplant is the treatment of choice for patients with end-stage liver disease. Patients with first graft failure requiring liver retransplant are commonly seen at most liver transplant...